Royal London Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-94,249
Closed -$1.96M 691
2023
Q2
$1.96M Hold
94,249
0.01% 620
2023
Q1
$2.22M Sell
94,249
-1,654
-2% -$44.4K 0.01% 597
2022
Q4
$2.68M Hold
95,903
0.01% 580
2022
Q3
$2.24M Hold
95,903
0.01% 582
2022
Q2
$3.24M Hold
95,903
0.01% 546
2022
Q1
$3.35M Buy
95,903
+12,774
+15% +$437K 0.01% 579
2021
Q4
$2.53M Hold
83,129
0.01% 601
2021
Q3
$2.73M Sell
83,129
-9,914
-11% -$317K 0.01% 600
2021
Q2
$2.81M Buy
+93,043
New +$3.06M 0.01% 613

Other funds holding OGN

Royal London Asset Management's OGN Position: Q3 2023 in Review

Royal London Asset Management sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 94,249 shares — an estimated $1.96M sold.

Royal London Asset Management first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $3.35M in Q1 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Royal London Asset Management reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Royal London Asset Management sold 94,249 Organon & Co shares in Q3 2023, an estimated $1.96M.
  • Royal London Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Royal London Asset Management's Organon & Co position peaked at $3.35M in Q1 2022.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Royal London Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.